Keywords: EMA, Pharmacovigilance, PRAC, Review. Servier, Vectarian, Diacerin, Hydroxyethyl starch, Short-acting beta blockers

Four new safety referrals evaluated as impact of new pharmacovigilance legislation kicks in, says EMA

Article | 02 December 2012

Print This

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) held its fifth meeting November 26-29, 2012, at which the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in